Changes in marrow adipose tissue in relation to changes in bone parameters following estradiol replacement in adolescent and young adult females with functional hypothalamic amenorrhea.

Abstract

Low energy availability causes disruption of hypothalamic gonadotropin-releasing hormone secretion leading to functional hypothalamic amenorrhea (FHA) and hypoestrogenism, which in turn contributes to decreased bone mineral density (BMD) and increased bone marrow adipose tissue (MAT). Transdermal estradiol administration in physiologic doses increases BMD in adolescents and adults with FHA. However, the impact of estrogen replacement on MAT in relation to changes in BMD has not been studied in adolescents and young adults. We hypothesized that physiologic estrogen replacement would lead to decreases in MAT, associated with increases in BMD. We studied 15 adolescent and young adult females with FHA (14-25years). All participants received a17β- estradiol transdermal patch at a dose of 0.1mg/day (applied twice weekly) for 12months. Participants also received cyclic progestin for 10-12days each month. We quantified MAT (lipid/water ratio) of the fourth lumbar (L4) vertebral body and femoral diaphysis by single proton (1H)-magnetic resonance spectroscopy, and compartmental volumetric BMD of the distal radius and tibia using high-resolution peripheral quantitative computed tomography. Transdermal estradiol therapy over 12months resulted in a decrease in MAT at the lumbar (L4) vertebra from 0.92±0.55 at baseline to 0.63±0.29 at 12-months (p=0.008), and an increase in radial and tibial cortical vBMD (p=0.006, p=0.0003). Changes in L4 MAT trended to be inversely associated with changes in radial cortical vBMD (rho=-0.47, p=0.08). We show that in adolescent and young adult girls with FHA, MAT decreases following transdermal estrogen therapy and these changes are associated with increased cortical vBMD.